Search research articles
Contact Us
Filters
Showing results (11-20 of 76) with videos related to
Page
of 8
Sort By:
Urologia
|
October 6, 2021
Bladder instillation for urinary tract infection prevention in neurogenic bladder patients practicing clean intermittent catheterization: A systematic review
Talal Ziadeh, Roy Chebel, Chris Labaki, et al.
The Oncologist
|
May 31, 2022
First-Line Treatments for Metastatic Clear Cell Renal Cell Carcinoma: An Ever-Enlarging Landscape
Shuchi Gulati, Chris Labaki, Georgia Sofia Karachaliou, et al.
European Urology Oncology
|
February 2, 2022
Towards a Better Understanding of Antibody-Drug Conjugates in Urothelial Carcinoma
Chris Labaki, Ziad Bakouny, Guru Sonpavde, et al.
Photodiagnosis and Photodynamic Therapy
|
February 2, 2021
The place of 5-aminolaevulinic acid-photodynamic therapy in the treatment landscape of urethral warts: A systematic review
Elio Kechichian, Elie Helou, Julien Sarkis, et al.
Critical Reviews in Oncology/Hematology
|
April 16, 2020
Anti-neoplastic agents for patients on peritoneal dialysis: A systematic review
Chris Labaki, Elsa Rawadi, Roy Chebel, et al.
Cancer Treatment Reviews
|
May 15, 2022
Systematic review of the CUP trials characteristics and perspectives for next-generation studies
Elie Rassy, Chris Labaki, Roy Chebel, et al.
World Journal of Urology
|
December 6, 2019
The use of mirabegron in neurogenic bladder: a systematic review
Elie El Helou, Chris Labaki, Roy Chebel, et al.
Hematology/Oncology Clinics of North America
|
June 30, 2023
Novel Immune Therapies for Renal Cell Carcinoma: Looking Beyond the Programmed Cell Death Protein 1 and Cytotoxic T-Lymphocyte-Associated Protein 4 Axes
Eddy Saad, Renée Maria Saliby, Chris Labaki, et al.
Hematology/Oncology Clinics of North America
|
June 29, 2023
Novel Targeted Therapies for Renal Cell Carcinoma: Building on the Successes of Vascular Endothelial Growth Factor and mTOR Inhibition
Renée Maria Saliby, Eddy Saad, Chris Labaki, et al.
Cancer Cell
|
July 15, 2021
Recovery of cancer screening tests and possible associated disparities after the first peak of the COVID-19 pandemic
Chris Labaki, Ziad Bakouny, Andrew Schmidt, et al.
Page
of 8
Search research articles
Search
Showing results (11-20 of 76) with videos related to
Sort By:
Page
of 8
Urologia
|
October 6, 2021
Bladder instillation for urinary tract infection prevention in neurogenic bladder patients practicing clean intermittent catheterization: A systematic review
Talal Ziadeh, Roy Chebel, Chris Labaki, et al.
The Oncologist
|
May 31, 2022
First-Line Treatments for Metastatic Clear Cell Renal Cell Carcinoma: An Ever-Enlarging Landscape
Shuchi Gulati, Chris Labaki, Georgia Sofia Karachaliou, et al.
European Urology Oncology
|
February 2, 2022
Towards a Better Understanding of Antibody-Drug Conjugates in Urothelial Carcinoma
Chris Labaki, Ziad Bakouny, Guru Sonpavde, et al.
Photodiagnosis and Photodynamic Therapy
|
February 2, 2021
The place of 5-aminolaevulinic acid-photodynamic therapy in the treatment landscape of urethral warts: A systematic review
Elio Kechichian, Elie Helou, Julien Sarkis, et al.
Critical Reviews in Oncology/Hematology
|
April 16, 2020
Anti-neoplastic agents for patients on peritoneal dialysis: A systematic review
Chris Labaki, Elsa Rawadi, Roy Chebel, et al.
Cancer Treatment Reviews
|
May 15, 2022
Systematic review of the CUP trials characteristics and perspectives for next-generation studies
Elie Rassy, Chris Labaki, Roy Chebel, et al.
World Journal of Urology
|
December 6, 2019
The use of mirabegron in neurogenic bladder: a systematic review
Elie El Helou, Chris Labaki, Roy Chebel, et al.
Hematology/Oncology Clinics of North America
|
June 30, 2023
Novel Immune Therapies for Renal Cell Carcinoma: Looking Beyond the Programmed Cell Death Protein 1 and Cytotoxic T-Lymphocyte-Associated Protein 4 Axes
Eddy Saad, Renée Maria Saliby, Chris Labaki, et al.
Hematology/Oncology Clinics of North America
|
June 29, 2023
Novel Targeted Therapies for Renal Cell Carcinoma: Building on the Successes of Vascular Endothelial Growth Factor and mTOR Inhibition
Renée Maria Saliby, Eddy Saad, Chris Labaki, et al.
Cancer Cell
|
July 15, 2021
Recovery of cancer screening tests and possible associated disparities after the first peak of the COVID-19 pandemic
Chris Labaki, Ziad Bakouny, Andrew Schmidt, et al.
Page
of 8